
Citinova P 500mg/800mg Tablet
Marketer
Ipca Laboratories Ltd
Salt Composition
Citicoline (500mg) + Piracetam (800mg)
Overview Citinova P 500mg/800mg Tablet
NeuroMend 500mg/800mg tablets aid in stroke recovery and cognitive function enhancement. This medication safeguards brain cells from injury and promotes their repair, also finding application in brain injury management. NeuroMend 500mg/800mg can be administered with or without food, ideally at the same time daily for consistent blood levels. Follow your physician's prescribed dosage and duration; if a dose is missed, take it immediately upon recall. Complete the entire course, even with symptom improvement, and never discontinue use abruptly without consulting your doctor, as this could exacerbate symptoms. Potential side effects, including restlessness, abdominal discomfort, anxiety, and low blood pressure, are typically transient and self-limiting. Persistent or bothersome effects warrant medical attention. Maintain adequate hydration due to potential diarrhea, and manage potential weight gain through balanced nutrition and exercise.
Uses of Citinova P 500mg/800mg Tablet
Stroke Recovery Program
Major Benefits of Citinova P 500mg/800mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Citinova P 500mg/800mg Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Consumption with or without food is acceptable, although consistent timing is recommended.
Common Side effects of Citinova P 500mg/800mg Tablet:
- Weight gain
- Hyperactivity
- Stomach pain
- Nervousness
- Diarrhea
- Decreased blood pressure
- Uncoordinated body movements
- Dizziness
How to use Citinova P 500mg/800mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Citinova P 500mg/800mg Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. These tablets can be administered with or without food, although consistent timing is recommended.
How Citinova P 500mg/800mg Tablet works:
Citinova P, a 500mg/800mg combination tablet of Citicoline and Piracetam, offers neuroprotective benefits. Citicoline acts as a neuronal nutrient, shielding nerve cells from injury, promoting their viability and overall health. Piracetam, a GABA analog, provides cerebral and neurological protection against hypoxic conditions, while also modulating the activity of various ion channels within neuronal membranes.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Citinova P 500mg/800mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Citinova P 500mg/800mg Tablet in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Citinova P 500mg/800mg tablets while breastfeeding is currently unavailable. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Citinova P 500mg/800mg Tablet, a medication that can induce drowsiness and tremors. Side effects from Citinova P 500mg/800mg Tablet include potential impacts on driving capabilities.
KidneyCAUTION
Patients with kidney impairment should exercise caution when taking Citinova P 500mg/800mg tablets, as dose modification may be necessary. Individuals with severe kidney disease should avoid this medication; a physician's consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Citinova P 500mg/800mg tablets in patients with hepatic impairment is likely safe, with existing evidence indicating that dosage modification may be unnecessary. However, physician consultation is recommended.
What if you forget to take Citinova P 500mg/800mg Tablet :
Should you forget a Citinova P 500mg/800mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Citinova P 500mg/800mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience |
